Cross-Border Strategy & Market Entry
Entering the U.S. market and adjusting cross-border exposure require navigating legal, regulatory, political, and cultural complexity that no playbook fully covers. Artisan Business Group provides senior advisory to Asian companies, investors, and family offices — from initial feasibility through partner selection, regulatory positioning, go-to-market execution, and China-plus-one supply-chain diversification.
The Problem
The U.S. market rewards companies that arrive with clear positioning, the right local partners, and an understanding of the regulatory environment — and is unforgiving to those who don't. For companies with Chinese ownership or backing, the regulatory environment has changed dramatically: CFIUS scrutiny, federal and state procurement restrictions, and reputational risk from Chinese-linked ownership require careful planning before the first dollar is invested. At the same time, trade-policy volatility, tariff escalation, UFLPA enforcement, and geopolitical risk have forced companies worldwide to reassess China-concentrated supply chains — and moving them is expensive, slow, and risky. The wrong alternative market can exchange China-concentration risk for new quality, compliance, or geopolitical risks.
How We Help
- Market feasibility and sizing — assessing whether and where a U.S. opportunity exists for your product or service
- Regulatory and CFIUS pre-screening — identifying ownership-structure and investment-category risks before entry
- Entity-structure advisory — recommending the right corporate structure for U.S. operations
- Partner and distributor identification — vetting potential U.S. partners, distributors, and local hires
- Go-to-market planning — developing a U.S. customer acquisition strategy tailored to your sector
- Supply-chain exposure mapping — identifying which inputs, SKUs, and revenue streams carry the most China-concentration risk
- Alternative-market assessment — evaluating Vietnam, India, Thailand, Indonesia, Mexico, and other candidate markets on cost, quality, capacity, and regulatory factors
- Supplier identification and vetting — identifying and conducting due diligence on alternative suppliers, with transition planning that protects margins and maintains quality
Our Process
Feasibility & Market Assessment
Size the opportunity, identify competitors, and assess whether the U.S. market fits your product and timeline.
Regulatory Pre-Screen
Identify CFIUS, export-control, procurement, and ownership-disclosure issues before committing capital.
Entry-Structure Design
Recommend the right corporate structure — wholly owned subsidiary, JV, licensing, distribution — for your goals and risk tolerance.
Partner & Talent Vetting
Identify and vet U.S. partners, distributors, advisors, and key hires.
Supply-Chain Exposure & Diversification
Map China-concentration exposure and evaluate China-plus-one alternative sourcing markets and suppliers.
Go-to-Market Execution Support
Support your first year of U.S. operations with market intelligence, introductions, and strategic guidance.
Who This Is For
- Asian companies planning to establish U.S. operations or subsidiaries
- Chinese manufacturers seeking to build a U.S. commercial presence
- Asian family offices making their first U.S. direct investments
- Technology companies from Taiwan, Korea, Japan, or Southeast Asia entering U.S. enterprise or government markets
- U.S. importers and manufacturers with heavy China-sourcing concentration seeking China-plus-one diversification
- Industrial companies evaluating Vietnam, India, or Southeast Asia as alternative manufacturing bases
- Investors and private-equity firms assessing supply-chain risk in portfolio company acquisitions
Frequently Asked Questions
What are the biggest mistakes Asian companies make entering the U.S. market?
The most common mistakes: (1) underestimating the regulatory environment, especially CFIUS and procurement restrictions for Chinese-linked companies; (2) choosing a U.S. partner or distributor based on relationship rather than market capability; (3) pricing for home-market margins rather than U.S. competitive dynamics; (4) underestimating the legal and HR compliance burden of employing U.S. workers; and (5) entering without a U.S.-credible brand or reference-customer strategy. These are fixable with preparation — but they are expensive to fix after launch.
Does Chinese ownership of my company affect U.S. market entry?
Significantly, in some sectors. Chinese beneficial ownership — even minority ownership — can trigger CFIUS review of U.S. acquisitions, bar companies from federal procurement contracts, and create reputational risk with U.S. enterprise customers in defense-adjacent, technology, and government sectors. The impact varies by industry: a Chinese-owned company selling consumer goods faces different constraints than one selling semiconductor equipment or defense-related services. An early regulatory pre-screen is essential to understand which markets are accessible and what structural adjustments, if any, make sense.
What is China-Plus-One, and why is it accelerating?
China-Plus-One is a sourcing strategy in which companies maintain their China manufacturing base while adding at least one alternative sourcing country to reduce concentration risk. It is accelerating for four overlapping reasons: Section 301 tariffs that have never been fully rolled back; UFLPA enforcement that creates compliance costs and detention risk for Chinese-sourced goods; growing contingency planning for a Taiwan scenario in which U.S.–China trade could be severely disrupted; and customer and investor pressure on ESG and supply-chain transparency.
What are the best alternative sourcing countries to China?
The right alternative depends on the product. Vietnam leads for apparel, footwear, electronics assembly, and furniture — but is at capacity in many categories and faces its own China-nexus scrutiny for transshipment. India is competitive for pharmaceuticals, chemicals, textiles, and engineering goods. Thailand and Indonesia work well for electronics, automotive parts, and consumer goods. Mexico offers nearshoring advantages for companies that benefit from USMCA tariff treatment and proximity to U.S. customers. Each market has specific capability gaps, labor-cost trajectories, and regulatory environments that must be evaluated for your specific product.
How long does it take to establish a U.S. operational presence?
Incorporating a U.S. subsidiary takes days; being commercially ready takes longer. A realistic first-year timeline: months one to two for entity formation, regulatory screening, and leadership hiring; months three to six for partner identification, product localization, and first customer relationships; months seven to twelve for go-to-market execution and revenue generation. Companies that try to compress this timeline by skipping the regulatory and partner-vetting steps typically face expensive course corrections.
Does moving supply chain out of China eliminate UFLPA risk?
Not automatically. CBP is increasingly focused on transshipment — goods manufactured in China (including Xinjiang inputs) and then finished in Vietnam, Cambodia, or other countries before being exported to the U.S. Simply moving final assembly outside China does not eliminate UFLPA risk if the upstream materials and components still have Xinjiang nexus. A genuine China-Plus-One strategy requires tracing the supply chain back to raw-material origin in the alternative country.
Related Insights
Don't navigate this exposure alone.
Get a confidential, firsthand read from Brian B. Su — and a clear next step.
Book a ConsultationRelated Services
Engagements available as Intelligence Briefs, Project Engagements, or Retained Advisory. See how we work →
